Top Markets
#1 Gama Token Gama Token +9.13%
#2 Audiera Audiera +4.96%
#3 Akedo Akedo +4.75%
#4 Nexpace Nexpace +4.13%
#5 Cross Cross +3.76%
#6 Ontology Gas Ontology Gas +3.64%
#7 Holoworld Holoworld +3.39%
#8 Velvet Velvet +3.01%
#9 Humanity Humanity +2.82%
#10 Perle Perle +2.77%
Coin of the day
Gama Token Gama Token
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Clasificación en acciones #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Precio por acción
$1.73
Última sincronización: 2025-06-17
Capitalización bursátil
$2.55M
Cambio (1 día)
-0.29%
Cambio (1 año)
0.00%
País
US
Comercio Eiger BioPharmaceuticals, Inc. (EIGR)

Categoría

Healthcare
Historial del precio de la acción de Eiger BioPharmaceuticals, Inc. (EIGR)
Precio más alto de cierre: $1.73 el 2025-06-01

Precio más bajo de cierre: $3.75K el 2014-01-01
Historial del precio de la acción de Eiger BioPharmaceuticals, Inc. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2025 -31.11%
2024 -68.15%
2023 -86.27%
2022 -65.86%
2021 -43.34%
2020 -27.82%
2019 28.55%
2018 -15.78%
2017 8.44%
2016 -45.90%
2015 -91.44%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE